Metabolic Bone Disease - Pathophysiology and Treatment

OR29-2

OR29-3

Individual Trabecula Segmentation Reveals Impaired Microarchitecture in Oligo-Amenorrheic Athletes Compared with Eumenorrheic Athletes
Deborah M Mitchell, Padrig Tuck, Kathryn E Ackerman, Ryan M Woolley, Natalia Cano Sokoloff, Meghan Slattery and Madhusmita Misra

OR29-4

Significantly Improved Muscle Strength, Running Speed, and Agility in Children with Hypophosphatasia Treated with Asfotase Alfa
Dawn Phillips, Kimberly Hamilton, Scott Moseley, Tatjana Odrljin, Kenji P Fujita, Amy L Reeves, Amy Yakimoski, Katherine L Madson, Cheryl Rockman-Greenberg and Michael P. Whyte

OR29-5

The Effect of High Dose Oral 17ß Estradiol on Bone Mineralization in Young Women with Turner Syndrome - a 5 Year Randomized Controlled Clinical Trial
Line Hartvig Cleemann, Kirsten Holm, Hanne Kobbernagel, Bent Kristensen, Sven Oluf Skouby, Andreas Emil Kryger Jensen and Claus H. Gravholt

OR29-6

Successful Treatment of a Mouse Model of Autosomal Dominant Osteopetrosis Type II (ADO2) with Interferon Gamma, but Not Cacitriol
Imranul Alam, Amie K Gray, Dena Acton, Rita L. Gerard-O'Riley and Michael John Econs